One Case of Anaphylactic Shock Caused by Multiple Oral Cephalexin Capsules Combined with Oolong Tea

doi:10.19803/j.1672-8629.20240677

Abstract

Abstract: Objective To explore the possible causes of anaphylactic shock after repeated use of cephalexin and to provide a reference for safe clinical use. Methods The possible causes of anaphylactic shock in a 37-year-old woman who had taken cephalexin capsules orally several times and then used the drug together with oolong tea one month later were analyze based on related literature. Results The cause of anaphylactic shock in this patient was unclear, which might be related to hypersensitivity caused by cephalexin and interactions between foods. Conclusion The use of cephalosporin antibiotics demands close attention to adverse drug reactions. Clinicians ought to monitor patients who have used this drug but have developed no adverse reactions.

Key words: Cephalexin Capsules, Anaphylactic Shock, Adverse Drug Reaction, Interaction

CLC Number:

R978
R994.11

FU Xiaoyan, GOU Yu, LUO Xianhai, HU Qiaozhi. One Case of Anaphylactic Shock Caused by Multiple Oral Cephalexin Capsules Combined with Oolong Tea[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 341-342.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240677

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I3/341

References

[1] ZHANG HB.Analysis of Severe Adverse Reactions of Cefalexin in 36 Cases[J].Chinese and Foreign Medical Research(中外医学研究),2013, 11(18): 65-66.
[2] YANG P, DAI DD, LI QY, et al.A Multicenter Clinical Study on the Incidence and Influencing Factors of Cephalosporin-Induced Anaphylaxis[J].Journal of Zhejiang University(浙江大学学报),2024, 53(5): 615-622.
[3] GUAN XC, GENG DL, DUAN M.A Retrospective Analysis of Adverse Drug Reactions Caused by Cephalosporin Antibacterial Drugs in a Certain Hospital[J].Journal of China Prescription Drug(中国处方药),2024, 22(8): 95-97.
[4] JIANG RJ, TAN SY, WANG Y, et al.One Case of Severe Allergic Shock Caused by Misoprostol Tablets[J].Chinese Journal of Pharmaco-vigilance(中国药物警戒),2024, 21(10): 1175-1177.
[5] LI X, MA Q, YIN J, et al.A Clinical Practice Guideline for the Emergency Management of Anaphylaxis(2020)[J].Front Pharmacol, 2022, 13: 845689.
[6] WILKERSON RG.Drug Hypersensitivity Reactions[J].Immunology and Allergy Clinics of North America, 2023, 43(3): 473-489.
[7] MIRAKIAN R, LEECH SC, KRISHNA MT, et al.Standards of Care Committee of the British Society for Allergy and Clinical Immunology. Management of Allergy to Penicillin and Other Beta-Lactams[J].Clinical and Experimental Allergy, 2015, 45(2): 300-327.
[8] BANKS TA, TUCKER M, MACY E.Evaluating Penicillin Allergies without Skin Testing[J].Current Allergy and Asthma Reports, 2019, 19(5): 27.
[9] FELDMAN R, JASZCZENSKI R.Can Metronidazole Cause a Disulfiram-Like Reaction? a Case-Control Study Propensity Matched by Age, Sex, and Ethanol Concentration[J].World Medical Journal, 2023, 122(3): 171-177.
[10] YANG X, CUI JH, TANG XH.Progress of Clinical Research on Disulfiram-Like Reaction[J].Journal of Modern Medicine & Health(现代医药卫生),2021, 37(6): 982-998.
[11] PANDEY E, GARG S. Vinegar-Induced Disulfiram Reaction[J].The Primary Care Companion for CNS Disorders, 2023, 25(6): 23cr03537.
[12] LI JQ.The Clinical Analysis of Disulfiram-Like Reaction Symptoms Mainly in Circulatory System[J].Chinese and Foreign Medical Research(中外医学研究),2016, 14(4): 121-123.
[13] CHEN C, DENG L, LIU QS, et al.Analysis of Reports of Allergic Shock in Chongqing between 2015 and 2020[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2023, 20(4): 460-464.
[14] CARUSO C, VALLUZZI RL, COLANTUONO S, et al.β-Lactam Allergy and Cross-Reactivity: a Clinician's Guide to Selecting an Alternative Antibiotic[J].J Asthma Allergy, 2021, 14: 31-46.

[1]	LONG Minjuan, ZHAO Xu, GUO Longxin, CAI Yuhan, LIN Li, ZHU Shengkai, LIU Wenlong, SONG Haibo, XIAO Xiaohe. Big Data Analysis of Liver Adverse Reactions Monitoring of Chinese and Western Medicines Based on Age Correction and Risk Warning for Dermatologic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 271-275.
[2]	LIAO Mengfan, ZHONG Liling, XU Yan, LIU Ying, ZHANG Yexiang, CHEN Qingsong, LIU Xudong. Adverse Reactions to Antihypertensive and Hypoglycaemic Drugs Based on Spontaneous Presentation Systems [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 286-291.
[3]	LIU Chenpei, DU Yupeng, LIN Yan. One Case of Anemia Caused by Finerenone Tablets [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 334-336.
[4]	HU Kun, HUANG Weiguo, LEI Lili, PANG Xiaocong, ZHOU Ying, CUI Yimin. One Case of Bone Marrow Suppression Caused by Azathioprine Tablets in a Patient with TPMT Heterozygous Mutation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 337-340.
[5]	YU Li, TAN Xiying. One Case of Acute Hepatic Injury Caused by Ioversol Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 343-345.
[6]	MIN Qiong, LI Peng, DAI Xiaoyan, FAN Chunling, YOU Haisheng. One Case of Neurotoxicity Caused by Fluorouracil Injection in a Patient with Metastatic Colorectal Cancer [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 346-348.
[7]	ZHU Lan, SHAO Bo, ZHU Yan, DAI Jie, ZHONG Shiqi. Current Progress and Considerations in Updating the Safety Information in Labels of Chinese Traditional Patent Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 188-192.
[8]	LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe. Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
[9]	LI Xiaobo, ZHOU Guojian, HUANG Yuling, LI Haiqiao, CHEN Tingting. One Case of Red Man Syndrome Caused by Locally-Used Low-Dose Vancomycin [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 217-220.
[10]	WANG Songlan, SUN Ying, CHEN Aiqun, JI Liwei. One Case of Acute Kidney Injury Induced by Evolocumab Injection in a Patient with Chronic Kidney Disease after Renal Transplantation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 221-223.
[11]	HU Yaping, ZHANG Aiwu. One Case of Acute Drug-Induced Liver Injury Caused by Tingli Jiangxuezhi Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 224-226.
[12]	KOU Jiejian, WANG Yangai. One Case of Thrombocytopenia and Leukopenia Induced by Teicolanin and Rebabapide [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 227-230.
[13]	NIE Xiaolu, SUN Feng, YAN Aixia, PENG Xiaoxia, ZHAN Siyan. Methodology for Constructing Benchmark Database of Adverse Drug Reactions Based on Multi-Source Information [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 10-15.
[14]	NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan. Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
[15]	SHAO Bo, ZHONG Lumiao, CHENG Yuzhu, DENG Hua, ZHU Lan. Risks to Safety of Yinhuang Oral Preparation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 84-87.